NCT02790281View on ClinicalTrials.gov

A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Inflammatory Bowel Disease
Interventions
PROCEDURE

Blood sampling

Blood sample collected at a single visit

Trial Locations (2)

Unknown

Herlev hospital (there may be other sites in this country), Herlev

Skane University Hospital (there may be other sites in this country), Lund

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT02790281 - A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter